Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

BioAge Labs, Inc. (BIOA) vs Siga Technologies Inc. (SIGA)

BioAge Labs, Inc. and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. BioAge Labs, Inc. is the larger, with a market value of $337.4M against $233.5M — 1.4× the size. Siga Technologies Inc. has the higher net margin (−5.19% vs −912.3%) and the higher return on invested capital (−14.6% vs −118.3%). Across the 15 metrics below, Siga Technologies Inc. leads on 11 and BioAge Labs, Inc. on 4.

Valuation

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 30.53 4.61 2.25
P/B 0.84 1.50 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA 0.00 n/m 12.29
EV/Sales (0.04) 2.45 2.56
Earnings yield (33.76%) (1.16%) (2.99%)
Free cash flow yield (76.82%) (8.29%) 0.00%

Profitability

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
Gross margin 100.00% 54.35% 53.94%
Operating margin (1,026.28%) (20.76%) 0.00%
Net margin (912.25%) (5.19%) 0.00%
Free cash flow margin (2,345.11%) (37.58%) 0.00%
Return on equity (28.21%) (1.49%) (0.40%)
Return on assets (26.27%) (1.36%) (3.32%)
Return on invested capital (118.25%) (14.59%) 0.00%

Growth

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (70.13%) 10.01%
EPS growth (last fiscal year) 66.21% (60.98%) —
Revenue growth, 5-year CAGR — (5.42%) 6.74%
Net income growth, 5-year CAGR — (16.20%) 0.00%

Health

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 17.19 21.72 2.31
Net debt to EBITDA 3.01 (6.39) 0.85

Dividend

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.70%
Payout ratio — 0.00 0.00

Size

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
Market cap 337.35m 233.51m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack